Microplastics in heart attack patients
Part of Heart & circulation clinical trials.
This trial looks for tiny plastic particles (microplastics and nanoplastics) in blood clots from people having a severe heart attack (STEMI) who need a procedure to open a blocked artery. It may help us understand if these particles are linked to heart attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You are having a severe heart attack (called STEMI) and need urgent heart catheterization
- Your heart attack is caused by a complete or near-complete blocked artery
- Your doctor plans to use a suction device (thromboaspiration) to remove the clot
- You are able to understand and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for tiny plastic particles in the blood of people with chronic heart artery disease. You will have a standard CT scan and an invasive angiogram anyway, and researchers will check your blood samples for microplastics.
This study looks at whether tiny plastic particles in the environment affect the small blood vessels of the heart and future heart health. If you are scheduled for a heart catheterization to check your arteries, you may be able to join.
This trial tests whether adding a low dose of a clot-busting medicine to the standard emergency procedure to open blocked heart arteries can improve outcomes for people having a heart attack. It aims to see if the combination is safe and more effective than the standard procedure alone.
This trial checks whether tiny plastic particles (microplastics) are present in the liver and body of people with cirrhosis who are having planned surgery or a liver transplant. It aims to understand if microplastics might make liver disease worse.
This study checks whether microplastics and nanoplastics can be detected in people undergoing neurosurgery. If it works, it could help doctors better understand possible material exposures around brain and nerve procedures.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
Hear when a new Microplastics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.